Phase II Trial of Erlotinib Monotherapy for Pretreated Elderly Patients with Advanced EGFR Wild-Type Non-Small-Cell Lung Cancer

被引：0
|
作者：
Minemura, Hiroyuki [1 ]
Yokouchi, Hiroshi [1 ]
Azuma, Keisuke [1 ]
Hirai, Kenichiro [1 ]
Sekine, Satoko [1 ]
Oshima, Kengo [1 ]
Kanazawa, Kenya [1 ]
Tanino, Yoshinori [1 ]
Inokoshi, Yayoi [2 ]
Ishii, Taeko [2 ]
Katsuura, Yutaka [2 ]
Oishi, Akio [3 ]
Ishida, Takashi [1 ]
Munakata, Mitsuru [1 ]
机构：
[1] Fukushima Med Univ, Dept Pulm Med, Fukushima, Japan
[2] Saiseikai Fukushima Gen Hosp, Dept Pulm Med, Fukushima, Japan
[3] Fukushima Red Cross Hosp, Dept Thorac Surg, Fukushima, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
elderly; Non-small-cell lung cancer; Erlotinib; EGFR wild-type;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-074
引用
收藏
页码：S547 / S547
页数：1
相关论文
共 50 条
  • [1] A phase II trial of erlotinib monotherapy for pretreated elderly patients with advanced EGFR wild-type non-small cell lung cancer Cancer
    Minemura H.
    Yokouchi H.
    Azuma K.
    Hirai K.-I.
    Sekine S.
    Oshima K.
    Kanazawa K.
    Tanino Y.
    Inokoshi Y.
    Ishii T.
    Katsuura Y.
    Oishi A.
    Ishida T.
    Munakata M.
    [J]. BMC Research Notes, 8 (1)
  • [2] A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer
    Takashi Kobayashi
    Tomonobu Koizumi
    Toshihide Agatsuma
    Masanori Yasuo
    Kenji Tsushima
    Keishi Kubo
    Seiichiro Eda
    Hiroshi Kuraishi
    Shigeru Koyama
    Tsutomu Hachiya
    Nariaki Ohura
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 69 : 1241 - 1246
  • [3] A phase II trial of erlotinib in patients with EGFR wild-type advanced non-small-cell lung cancer
    Kobayashi, Takashi
    Koizumi, Tomonobu
    Agatsuma, Toshihide
    Yasuo, Masanori
    Tsushima, Kenji
    Kubo, Keishi
    Eda, Seiichiro
    Kuraishi, Hiroshi
    Koyama, Shigeru
    Hachiya, Tsutomu
    Ohura, Nariaki
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (05) : 1241 - 1246
  • [4] Role of erlotinib in the treatment of advanced non-small-cell lung cancer patients with EGFR wild-type tumors
    Braun, Eduardo
    Bonomi, Philip
    [J]. LUNG CANCER MANAGEMENT, 2014, 3 (01) : 101 - 116
  • [5] Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, Lecia, V
    Gray, Jhanelle Elaine
    Harb, Wael A.
    Lopez-Chavez, Ariel
    Doebele, Robert C.
    Modiano, Manuel R.
    Jackman, David Michael
    Baggstrom, Maria Quintos
    Atmaca, Akin
    Felip, Enriqueta
    Provencio, Mariano
    Cobo, Manuel
    Adiwijaya, Bambang
    Kuesters, Geoffrey
    Kamoun, Walid S.
    Andreas, Karen
    Pipas, J. Marc
    Santillana, Sergio
    Cho, Byoung Chul
    Park, Keunchil
    Shepherd, Frances A.
    [J]. ONCOLOGIST, 2019, 24 (08): : 1095 - 1102
  • [6] Randomized Phase 2 Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer
    Sequist, L.
    Gray, J.
    Harb, W.
    Doebele, R.
    Modiano, M.
    Jackman, D.
    Baggstrom, M.
    Atmaca, A.
    Felip, E.
    Provencio, M.
    Cobo Dols, M.
    Adiwijaya, B.
    Kuesters, G.
    Kamoun, W.
    Andreas, K.
    Pipas, J.
    Santillana, S.
    Cho, B. C.
    Park, K.
    Shepherd, F.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S596 - S596
  • [7] Capmatinib plus nivolumab in pretreated patients with EGFR wild-type advanced non-small cell lung cancer
    Felip, Enriqueta
    Metro, Giulio
    Tan, Daniel S. W.
    Wolf, Juergen
    Mark, Michael
    Boyer, Michael
    Hughes, Brett G. M.
    Bearz, Alessandra
    Moro-Sibilot, Denis
    Le, Xiuning
    Puente, Javier
    Massuti, Bartomeu
    Tiedt, Ralph
    Wang, Yingying
    Xu, Chao
    Mardjuadi, Feby I.
    Cobo, Manuel
    [J]. LUNG CANCER, 2024, 192
  • [8] Phase II Study of Pemetrexed and Erlotinib in Pretreated Nonsquamous, Non-Small-Cell Lung Cancer Patients without an EGFR mutation
    Kim, Young Hak
    Nishimura, Takashi
    Ozasa, Hiroaki
    Nagai, Hiroki
    Sakamori, Yuichi
    Iwata, Toshiyuki
    Sunadome, Hironobu
    Nishimura, Tomoko
    Mishima, Michiaki
    [J]. CHEMOTHERAPY, 2013, 59 (06) : 414 - 419
  • [9] Safety and Efficacy of Dacomitinib in Korean Patients with KRAS Wild-Type Advanced Non-Small-Cell Lung Cancer Refractory to Chemotherapy and Erlotinib or Gefitinib A Phase I/II Trial
    Park, Keunchil
    Cho, Byoung C.
    Kim, Dong-Wan
    Ahn, Myung-Ju
    Lee, Sang-Yoon
    Gernhardt, Diana
    Taylor, Ian
    Campbell, Alicyn K.
    Zhang, Hui
    Giri, Nagdeep
    Letrent, Stephen P.
    O'Connell, Joseph
    Heo, Dae S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (10) : 1523 - 1531
  • [10] Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non-Small-Cell Lung Cancer
    Spigel, David R.
    Ervin, Thomas J.
    Ramlau, Rodryg A.
    Daniel, Davey B.
    Goldschmidt, Jerome H., Jr.
    Blumenschein, George R., Jr.
    Krzakowski, Maciej J.
    Robinet, Gilles
    Godbert, Benoit
    Barlesi, Fabrice
    Govindan, Ramaswamy
    Patel, Taral
    Orlov, Sergey V.
    Wertheim, Michael S.
    Yu, Wei
    Zha, Jiping
    Yauch, Robert L.
    Patel, Premal H.
    Phan, See-Chun
    Peterson, Amy C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (32) : 4105 - +
12345